PredictImmune

📍 Cambridge, United Kingdom🗓 Founded 2017👥 13 employees💰 Last funded Sep 2019
Hospitals and Health Care🌐 predictimmune.com
Website LinkedIn
PredictImmune develops pioneering tools for guiding personalised treatment options in immune-mediated diseases such as inflammatory bowel disease (IBD). Based on world-leading research at Cambridge University, UK, we are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payers all recognise the value of such an approach to the management of inflammatory bowel disease (IBD). www.predictimmune.com
3
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
3
Frequently asked questions
Who invested in PredictImmune?
PredictImmune has 3 investors on record on gritt.io, including 1 early-stage backers.
When did PredictImmune last raise funding?
The most recent investment in PredictImmune recorded on gritt.io was in September 2019.
When was PredictImmune founded?
PredictImmune was founded in 2017.
What industry is PredictImmune in?
PredictImmune operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is PredictImmune based?
PredictImmune is headquartered in Cambridge, United Kingdom.